Related Experiment Video
Updated: Aug 5, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Potential new targets for rheumatic diseases
1Rheumatologisches Versorgungszentrum (RVZ), Ruhr Universität Bochum und RVZ Steglitz, Berlin, Germany.
Abstract:
There are now many established and new targets for the treatment of autoimmune diseases, such as rheumatoid arthritis and connective tissue diseases. Treatment with conventional (c), biologic (b) and targeted synthetic (ts) disease-modifying antirheumatic drugs has become a daily routine in rheumatologic care, mainly but not only in secondary and tertiary centres. In addition, specialists in oncology, gastroenterology, dermatology, and others are using drugs targeting a whole spectrum of antigens in the immune system. This narrative review presents and shortly discusses several new targets and agents of potential use to treat rheumatic musculoskeletal diseases.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Pharmacogenomics: Identification of New Drug Targets